Technical Analysis for CDNA - CareDx, Inc.

Grade Last Price % Change Price Change
grade B 31.9 -3.94% -1.31
CDNA closed down 3.94 percent on Thursday, May 23, 2019, on 72 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical CDNA trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
NR7 Range Contraction -3.94%
Wide Bands Range Expansion -3.94%
Wide Bands Range Expansion -6.15%
Hammer Candlestick Bullish -1.63%
NR7 Range Contraction -1.63%
Wide Bands Range Expansion -1.63%
Overbought Stochastic Strength -1.63%
Upper Bollinger Band Walk Strength -2.60%

Older signals for CDNA ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
CareDx, Inc. develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime. It provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. The company also offers AlloMap Molecular Expression Testing, an in vitro diagnostic multivariate index assay test service performed in a single laboratory assessing the gene expression profile of RNA isolated from peripheral blood mononuclear cells. It markets and sells its products through distribution partners in the United States, Canada, and Europe. CareDx, Inc. was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in April 2014. The company was incorporated in 1998 and is based in Brisbane, California.
Medicine Medical Specialties Clinical Medicine Gene Expression Organ Transplantation Transplantation Medicine
Is CDNA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 39.38
52 Week Low 10.31
Average Volume 876,120
200-Day Moving Average 26.9127
50-Day Moving Average 31.241
20-Day Moving Average 31.0075
10-Day Moving Average 33.035
Average True Range 1.9474
ADX 28.37
+DI 27.764
-DI 19.7826
Chandelier Exit (Long, 3 ATRs ) 29.3278
Chandelier Exit (Short, 3 ATRs ) 31.6822
Upper Bollinger Band 35.846
Lower Bollinger Band 26.169
Percent B (%b) 0.59
BandWidth 31.208579
MACD Line 1.0101
MACD Signal Line 0.8084
MACD Histogram 0.2016
Fundamentals Value
Market Cap 719.05 Million
Num Shares 22.5 Million
EPS -1.39
Price-to-Earnings (P/E) Ratio -22.95
Price-to-Sales 2.74
Price-to-Book 10.33
PEG Ratio -0.35
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 33.96
Resistance 3 (R3) 33.99 33.34 33.61
Resistance 2 (R2) 33.34 32.82 33.32 33.50
Resistance 1 (R1) 32.62 32.49 32.30 32.59 33.38
Pivot Point 31.97 31.97 31.81 31.95 31.97
Support 1 (S1) 31.25 31.45 30.93 31.22 30.42
Support 2 (S2) 30.60 31.12 30.58 30.30
Support 3 (S3) 29.88 30.60 30.19
Support 4 (S4) 29.85